2006: Fake Blood Experiments Without Consent: Is Your City Participating? FDA: Closed Door Meeting

Scientists and entrepreneurs have tried for years to develop a safe and universal blood substitute that did not spoil after 42 days. However, all such efforts have encountered serious safety problems.
Continue reading →

Safety Issues: FDA Scientists Collide with FDA Managers

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.

Continue reading →

FDA Scientists Collide with FDA Managers Re: Safety Issues

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →

ACRE–A High Powered Harvard Stealth Pharma Front Group

ACRE’s mission is to persuade  physicians that MORE rather than less industry involvement in Continuing Medical Education programs is good for patients–much as industry’s "Harry and Louise" ads were aimed at convincing the public that universal healthcare was BAD for them. Continue reading →

Letter of Complaint to FDA Commissioner, 2007

vera_signature.png

Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without  an advisory panel or open public discussion.  Continue reading →